Immunoglobulin G4 (IgG4) Related Disease - Wesley Research Institute
Wesley Research Institute
Donate
Now

Testing new treatments for people with IgG4 related disease (fibro-inflammatory condition).

Research Objectives

Status

Completed

Recruitment

Closed

Patient Group

Adults aged ≥ 18 years who have recently active IgG4-RD (initial diagnosis or flare) that requires new or ongoing treatment, are at high risk of future flare, and meet the 2019 American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) IgG4-RD classification criteria.

Total Participants

2

Study location

The Wesley Hospital

Study type

Industry Sponsored
Sponsors: Viela Bio

Lead investigators

  • Dr Daman Langguth

Clinical Trial Coordinator

  • Venita Bali

Technical title

A Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Study of Inebilizumab Efficacy and Safety in Immunoglobulin G4-related disease (IgG4) Related Disease (MITIGATE)

About this research project

There are currently no medicinal products approved for the treatment of IgG4-RD. The majority of cases follow a relapsing course that can lead to permanent tissue damage with potential morbidity and mortality. This project aims to develop an effective product.

The purpose of this study is to better understand the safety and side effects of  Inebilizumab and to find out if it helps people with IgG4 related disease.

Latest News

Lung Cancer METASPATIAL Study awarded $1 million by the Australian Government

We’re delighted to announce that Dr Arutha Kulasinghe is leading the Lung Cancer METASPATIAL Study that has been awarded nearly $1m by the Australian Government. The project is supported by the Wesley Research Institute and the University of Queensland. The METASPATIAL Study will be undertaken over the next 4 years at Wesley Research Institute’s new Queensland Spatial Biology Centre (QSBC).

Lung Cancer Survivor Michel Itel an advocate for Spatial Mapping of Digital Pathology

As a patient with a specific EGFR positive mutation, Michel benefited from targeted therapy, an approach that the new Queensland Spatial Biology Centre (QSBC) aims to enhance for future patients.
Amanda

Amanda’s Story

Flashback to the middle of 2019, it was just like any other normal day at work for Amanda, until she noticed a lump in her groin.
1 2 3 8
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram